Michael G. Kaplitt

15.0k total citations · 3 hit papers
121 papers, 8.0k citations indexed

About

Michael G. Kaplitt is a scholar working on Cellular and Molecular Neuroscience, Neurology and Molecular Biology. According to data from OpenAlex, Michael G. Kaplitt has authored 121 papers receiving a total of 8.0k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Cellular and Molecular Neuroscience, 38 papers in Neurology and 37 papers in Molecular Biology. Recurrent topics in Michael G. Kaplitt's work include Virus-based gene therapy research (32 papers), Neurological disorders and treatments (32 papers) and Parkinson's Disease Mechanisms and Treatments (17 papers). Michael G. Kaplitt is often cited by papers focused on Virus-based gene therapy research (32 papers), Neurological disorders and treatments (32 papers) and Parkinson's Disease Mechanisms and Treatments (17 papers). Michael G. Kaplitt collaborates with scholars based in United States, New Zealand and Netherlands. Michael G. Kaplitt's co-authors include Donald W. Pfaff, Matthew J. During, Sanjay Salgado, David Eidelberg, Sergei Musatov, Paola Leone, R. Jude Samulski, Xiao Xiao, Karen L. O’Malley and Helen L. Fitzsimons and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Michael G. Kaplitt

120 papers receiving 7.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain

1994 834 citations Michael G. Kaplitt, Paola Leone et al. profile →
Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial

2007 775 citations Michael G. Kaplitt, Deborah Young et al. profile →
Disruption of mitochondrial complex I induces progressive parkinsonism

2021 332 citations Mihaela Stavarache, Michael G. Kaplitt et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael G. Kaplitt United States	45	3.4k	2.5k	2.5k	1.6k	995	121	8.0k
Krystof S. Bankiewicz United States	55	3.8k 1.1×	2.7k 1.1×	3.3k 1.4×	2.1k 1.3×	550 0.6×	153	8.4k
John Forsayeth United States	51	3.6k 1.1×	1.8k 0.7×	2.7k 1.1×	1.2k 0.7×	742 0.7×	118	6.6k
Corinna Bürger United States	39	2.7k 0.8×	1.4k 0.6×	2.3k 1.0×	1.6k 1.0×	720 0.7×	66	6.3k
Brian K. Kaspar United States	54	7.3k 2.2×	3.3k 1.3×	2.6k 1.0×	2.9k 1.8×	1.4k 1.5×	122	12.4k
Enza Maria Valente Italy	44	4.1k 1.2×	2.2k 0.9×	2.9k 1.2×	3.6k 2.2×	1.4k 1.4×	233	9.3k
Sachio Takashima Japan	47	2.2k 0.7×	880 0.4×	1.3k 0.5×	811 0.5×	1.1k 1.1×	328	8.3k
Kun Xia China	41	3.8k 1.1×	1.3k 0.5×	1.6k 0.6×	1.2k 0.8×	672 0.7×	403	7.0k
Lin Mei United States	69	9.5k 2.8×	1.4k 0.6×	5.3k 2.2×	2.0k 1.2×	1.9k 1.9×	257	16.3k
Sebastian Kügler Germany	47	4.1k 1.2×	992 0.4×	2.7k 1.1×	958 0.6×	1.3k 1.3×	124	7.7k
Ronald J. Mandel United States	50	6.5k 2.0×	4.5k 1.8×	4.7k 1.9×	3.0k 1.8×	1.0k 1.1×	95	12.2k

Countries citing papers authored by Michael G. Kaplitt

Since Specialization

Citations

This map shows the geographic impact of Michael G. Kaplitt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael G. Kaplitt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael G. Kaplitt more than expected).

Fields of papers citing papers by Michael G. Kaplitt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael G. Kaplitt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael G. Kaplitt. The network helps show where Michael G. Kaplitt may publish in the future.

Co-authorship network of co-authors of Michael G. Kaplitt

This figure shows the co-authorship network connecting the top 25 collaborators of Michael G. Kaplitt. A scholar is included among the top collaborators of Michael G. Kaplitt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael G. Kaplitt. Michael G. Kaplitt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Stavarache, Mihaela, et al.. (2025). Herpes Simplex Oncolytic Viral Therapy for Malignant Glioma and Mechanisms of Delivery. World Neurosurgery. 194. 123595–123595. 3 indexed citations

Martínez‐Fernández, Raúl, Steffen Paschen, Marta del Álamo, et al.. (2025). Focused ultrasound therapy for movement disorders. The Lancet Neurology. 24(8). 698–712. 3 indexed citations

Kokotos, Alexandros C., Santiago R. Unda, Myung S. Ko, et al.. (2024). Phosphoglycerate kinase is a central leverage point in Parkinson’s disease–driven neuronal metabolic deficits. Science Advances. 10(34). eadn6016–eadn6016. 11 indexed citations

Haikal, Caroline, et al.. (2024). Cognitive dysfunction in animal models of human lewy-body dementia. Frontiers in Aging Neuroscience. 16. 1369733–1369733. 3 indexed citations

Xie, Lili, Ling‐Ping Cen, Hui-ya Gilbert, et al.. (2022). Monocyte-derived SDF1 supports optic nerve regeneration and alters retinal ganglion cells’ response to Pten deletion. Proceedings of the National Academy of Sciences. 119(15). e2113751119–e2113751119. 37 indexed citations

Rosenberg, Jonathan B., Michael G. Kaplitt, Bishnu P. De, et al.. (2018). AAVrh.10-Mediated APOE2 Central Nervous System Gene Therapy for APOE4-Associated Alzheimer's Disease. PubMed. 29(1). 24–47. 123 indexed citations

Kovanlıkaya, İlhami, Linda Heier, & Michael G. Kaplitt. (2014). Treatment of Chronic Pain: Diffusion Tensor Imaging Identification of the Ventroposterolateral Nucleus Confirmed with Successful Deep Brain Stimulation. Stereotactic and Functional Neurosurgery. 92(6). 365–371. 15 indexed citations

Liu, Wencheng, Cristòfol Vives-Bauzá, Rebeca Acín‐Pérez, et al.. (2009). PINK1 Defect Causes Mitochondrial Dysfunction, Proteasomal Deficit and α-Synuclein Aggregation in Cell Culture Models of Parkinson's Disease. PLoS ONE. 4(2). e4597–e4597. 113 indexed citations

Schultz, Kristin N., Silke A. von Esenwein, Ming Hu, et al.. (2009). Viral Vector-Mediated Overexpression of Estrogen Receptor-α in Striatum Enhances the Estradiol-Induced Motor Activity in Female Rats and Estradiol-Modulated GABA Release. Journal of Neuroscience. 29(6). 1897–1903. 90 indexed citations

10.

Kaplitt, Michael G., et al.. (2009). Novel Mitochondrial Substrates of Omi Indicate a New Regulatory Role in Neurodegenerative Disorders. PLoS ONE. 4(9). e7100–e7100. 18 indexed citations

11.

Musatov, Sergei, Walter W. Chen, Donald W. Pfaff, Michael G. Kaplitt, & Sonoko Ogawa. (2006). RNAi-mediated silencing of estrogen receptor α in the ventromedial nucleus of hypothalamus abolishes female sexual behaviors. Proceedings of the National Academy of Sciences. 103(27). 10456–10460. 178 indexed citations

12.

Kaplitt, Michael G. & Matthew J. During. (2006). Gene therapy of the central nervous system : from bench to bedside. Academic Press eBooks. 24 indexed citations

13.

Chan, Dylan K., Frederick C. Roediger, Justin F. Fraser, et al.. (2006). AAV-Mediated Delivery of the Caspase Inhibitor XIAP Protects Against Cisplatin Ototoxicity. Otology & Neurotology. 27(4). 484–490. 53 indexed citations

14.

During, Matthew J., Ruian Xu, Deborah Young, et al.. (1998). Peroral gene therapy of lactose intolerance using an adeno-associated virus vector. Nature Medicine. 4(10). 1131–1135. 109 indexed citations

15.

Freese, Andrew, Michael G. Kaplitt, David Langer, et al.. (1997). Direct Gene Transfer Into Human Epileptogenic Hippocampal Tissue with an Adeno-Associated Virus Vector: Implications for a Gene Therapy Approach to Epilepsy. Epilepsia. 38(7). 759–766. 28 indexed citations

16.

Vogt, Lorenz, Roman J. Giger, Urs Ziegler, et al.. (1996). Continuous renewal of the axonal pathway sensor apparatus by insertion of new sensor molecules into the growth cone membrane. Current Biology. 6(9). 1153–1158. 54 indexed citations

17.

Freese, Andrew, et al.. (1996). Prospects for gene therapy in Parkinson's disease. Movement Disorders. 11(5). 469–488. 25 indexed citations

18.

Kaplitt, Michael G. & Arthur D. Loewy. (1995). Viral vectors : gene therapy and neuroscience applications. Academic Press eBooks. 79 indexed citations

19.

Verhaagen, Joost, Wim Th. Hermens, A.B. Oestreicher, et al.. (1994). Expression of the growth-associated protein B-50/GAP43 via a defective herpes-simplex virus vector results in profound morphological changes in non-neuronal cells. Molecular Brain Research. 26(1-2). 26–36. 34 indexed citations

20.

Kaplitt, Michael G., Juri G. Gelovani, David A. Leib, et al.. (1994). Mutant herpes simplex virus induced regression of tumors growing in immunocompetent rats. Journal of Neuro-Oncology. 19(2). 137–147. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact